TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
126.79
-0.83 (-0.65%)
At close: Dec 12, 2025, 4:00 PM EST
128.40
+1.61 (1.27%)
Pre-market: Dec 15, 2025, 7:10 AM EST

TransMedics Group Revenue

TransMedics Group had revenue of $143.82M in the quarter ending September 30, 2025, with 32.24% growth. This brings the company's revenue in the last twelve months to $566.35M, up 41.20% year-over-year. In the year 2024, TransMedics Group had annual revenue of $441.54M with 82.74% growth.

Revenue (ttm)
$566.35M
Revenue Growth
+41.20%
P/S Ratio
7.58
Revenue / Employee
$777,959
Employees
728
Market Cap
4.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024441.54M199.92M82.74%
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 201813.02M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings